Immunotech Biopharm Ltd

HK$0.38As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6978Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR (40.60%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.09
PE TTM —
TSR TTM (88.02%)
Mkt cap HK$231.6M
ROIC (33.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.39
4.05%
(12.67%)
Hold 7|4|5|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
11.11%
2.18%
7.47%
7.34%
Revenue¥M
16.27
16.89
17.10
17.42
(2.11%)
4.39%
0.63%
5.24%
Peers (US$29.54M)
Cap (US$)
PE
31.89M
—
29.46M
—
Capital
TTM
5Y
10Y
Leveragex
0.641
—
—
EBIT/Intx
4.768
0.300
0.299
Own earn%
87.82
224.24
242.03
Sh yield%
24.74
51.07
51.10
Owners
Insiders/Inst%
3.16
44.50
Short interest%
1.44
SBC / revenue%
5.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
18–23
$1 testx
—
Incr. ROIC%
26